Table 2.

Current clinical trials listed at www.clinicaltrials.gov (research August 2010) employing mesenchymal stromal cells from umbilical cord blood, umbilical cord or placenta or case studies applying mesenchymal stromal cells from perinatal sources

UCB-MSCs	Safety and efficacy study of umbilical cord blood-derived mesenchymal stem cells to promote engraftment of unrelated hematopoietic stem cell transplantation
UCB-MSCs	Safety and efficacy study of umbilical cord/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes
UCB-MSCs	Stem cell therapy for type 1 diabetes mellitus
UCB-MSCs	Study to compare the efficacy and safety of cartistem® and microfracture in patients with knee articular cartilage injury or defect
UC-MSCs	A research study looking at specific tissue of the umbilical cord
UC-MSCs	Allogeneic mesenchymal stem cell for Graft-versus-host disease treatment
UC-MSCs/Placenta-MSCs	Safety and efficacy study of umbilical cord/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes
Placenta-MSCs	Safety of intramuscular injection of Allogeneic PLX-PAD cells for the treatment of critical limb ischemia
UCB-MSCs	Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model[103]
UCB-MSCs	A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study[104]